Visual field defects after vigabatrin treatment during infancy: retrospective population‐based study-Reference-Cited by-同舟云学术

Visual field defects after vigabatrin treatment during infancy: retrospective population‐based study

Published:2021-10-30 Issue: Volume: Page:
ISSN:0012-1622
Container-title:Developmental Medicine & Child Neurology
language:en
Short-container-title:Dev Med Child Neurol

Author:

Jonsson Henna¹^ORCID,Lehto Mikko²,Vanhatalo Sampsa³⁴^ORCID,Gaily Eija¹,Linnankivi Tarja¹^ORCID

Affiliation:

1. Department of Pediatric Neurology New Children's Hospital and Pediatric Research Center Epilepsia Helsinki Helsinki University Hospital and University of Helsinki HelsinkiFinland

2. Department of Ophthalmology Helsinki University Hospital and University of Helsinki HelsinkiFinland

3. Department of Children's Clinical Neurophysiology BABA Center Department of Clinical Neurophysiology Children's Hospital Helsinki University Hospital HelsinkiFinland

4. Neuroscience Center Helsinki Institute of Life Science University of Helsinki Helsinki Finland

Funder

Lastentautien Tutkimussäätiö

Publisher

Wiley

Subject

Neurology (clinical),Developmental Neuroscience,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dmcn.15099

Reference30 articles.

1. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi‐centre randomised trial;Darke K;Arch Dis Child,2010

2. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study;O’Callaghan FJK;Epilepsia,2011